Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Current Assets (2016 - 2025)

Historic Current Assets for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $3.7 million.

  • International Stem Cell's Current Assets rose 699.14% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 699.14%. This contributed to the annual value of $3.6 million for FY2024, which is 110.76% up from last year.
  • Per International Stem Cell's latest filing, its Current Assets stood at $3.7 million for Q3 2025, which was up 699.14% from $3.8 million recorded in Q2 2025.
  • International Stem Cell's Current Assets' 5-year high stood at $3.8 million during Q2 2025, with a 5-year trough of $2.3 million in Q4 2021.
  • In the last 5 years, International Stem Cell's Current Assets had a median value of $3.5 million in 2024 and averaged $3.3 million.
  • Per our database at Business Quant, International Stem Cell's Current Assets crashed by 1801.06% in 2021 and then skyrocketed by 3548.15% in 2023.
  • International Stem Cell's Current Assets (Quarter) stood at $2.3 million in 2021, then rose by 26.95% to $3.0 million in 2022, then rose by 18.83% to $3.5 million in 2023, then rose by 1.11% to $3.6 million in 2024, then rose by 4.89% to $3.7 million in 2025.
  • Its last three reported values are $3.7 million in Q3 2025, $3.8 million for Q2 2025, and $3.8 million during Q1 2025.